NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global leader in medical cannabis research, cultivation, production, and distribution, today announced that Aphria RX GmbH ("Aphria RX") has received a trading license, which will allow it to sell and distribute a broad range of medical cannabis products to pharmacies, hospitals, and medical wholesalers throughout Germany. "This milestone of Aphria RX obtaining both its new cultivation license as ...